Cohen, E. N., et al. Antigen-agnostic microfluidics-based Circulating tumor cell enrichment and downstream molecular characterization. PLoS One. 2020 Oct 23;15(10):e0241123. doi: 10.1371/journal.pone.0241123. eCollection 2020.
Eaves, L. A., et al. A role for microRNAs in the epigenetic control of sexually dimorphic gene expression in the human placenta. Epigenomics 2020 SEP 9, Published online: ahead of print. https://doi.org/10.2217/epi-2020-0062
Armand, P., et. al. Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma. 2020 AUG 31. https://doi.org/10.1182/blood.2019004753
Finn, R., et al. Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 AND paloma-3 clinical trials. Breast Cancer Research and Treatment. 2020 AUG 11; https://doi.org/10.1007/s10549-020-05782-4
Xu-Monette, Z., et al. A refined cell-of-origin classifier with targeted NGS and artificial
intelligence shows robust predictive value in DLBCL. Blood Advances. 2020 JUL 28 (4)14:3391-3404.
Pass, H., et. al. Mesothelioma Biomarkers: A Review Highlighting Contributions from Early Detection Research Network. Cancer Epidemiology, Biomarkers & Prevention. 2020 Jul 21. DOI: 10.1158/1055-9965.EPI-20-0083
Payton, A., et al. Placental Genomic and Epigenomic Signatures Associated with Infant birth weight Highlight Mechanisms Involved in Collagen and Growth Factor Signalining. Reproductive Toxicology. 2020 Jul 25: Elsevier. In press.https://doi.org/10.1016/j.reprotox.2020.07.007
Bradbury, A., et al. Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response biomarkers for Therapeutic Targeting. Cancers: 2020 (12) 1939; doi:10.3390/cancers12071939
Bustos, M. A., et al. Integrated Assessment of Circulating Cell-Free MicroRNA signatures in Plasma of Patients With Melanoma Brain Metastasis. Cancers 2020, 12, 1692; doi:10.3390/cancers12061692
Page last updated October 26, 2020